Prospective study on GnRH analogues for ovarian function in women with gynecologic malignancies receiving chemotherapy [Prospektive Studie zur potentiellen Protektion der Ovarfunktion von Frauen mit gynakologischen Malignomen unter Chemotherapie mittels GnRH-Analoga-Applikation]

Trial Profile

Prospective study on GnRH analogues for ovarian function in women with gynecologic malignancies receiving chemotherapy [Prospektive Studie zur potentiellen Protektion der Ovarfunktion von Frauen mit gynakologischen Malignomen unter Chemotherapie mittels GnRH-Analoga-Applikation]

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Leuprorelin (Primary) ; Leuprorelin (Primary)
  • Indications Ovarian disorders
  • Focus Therapeutic Use
  • Acronyms Ovar-Protect
  • Most Recent Events

    • 11 Jun 2013 Status changed from recruiting to completed.
    • 07 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top